论文部分内容阅读
近年来,我们对90例脑性瘫痪病人随机分为促甲状腺素释放激素(TRH)组(下称A组)、脑移植组(下称B组)和脑移植加TRH组(下称C组)进行治疗,结果证明,C组近期疗效较好。 临床资料:本组年龄2.5～21岁;男65例,女25例;均经多种神经营养药物等综合治疗无效。病人以痉挛型脑性瘫痪和智能落后为主要临床症状,50％有癫痫发作史。
In recent years, 90 patients with cerebral palsy were randomly divided into three groups: thyrotropin-releasing hormone (TRH) group (group A), brain transplantation group (group B) and brain transplantation plus TRH group ) For treatment, the results show that C group is better in the near future. Clinical data: The age group of 2.5 to 21 years old; 65 males and 25 females; all by a variety of neurotrophic drugs and other comprehensive treatment ineffective. Patients with spastic cerebral palsy and mental retardation as the main clinical symptoms, 50% had a history of seizures.